Charles Conroy, Nucleus RadioPharma CEO
October 17, 2023 07:30 AM EDT
Financing
Manufacturing

Mayo Clin­ic-backed Nu­cle­us Ra­dio­Phar­ma rais­es $56M in Se­ries A to boost CD­MO ser­vices

Anna Brown

News Reporter

Nu­cle­us Ra­dio­Phar­ma is mak­ing a splash with an over­sub­scribed $56 mil­lion Se­ries A to prop up the CD­MO’s man­u­fac­tur­ing ca­pac­i­ty, with a Rochester, MN site …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ideaya inks ADC deal with $75M up­front; Amy­lyx, Gubra to de­vel­op long-act­ing GLP-1

De­spite mixed da­ta in Alzheimer's ag­i­ta­tion, Ax­some will still seek FDA ap­proval

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

A service from the Financial Times